In October of this year the bank cleared Credit Suisse CEO Tidjane Thiam of snooping on former wealth management boss Iqbal Khan in an episode that saw suicide, scandal and espionage invade the secretive world of Swiss private banking. (© Keystone / Ennio Leanza) A senior Credit Suisse human resources executive was tailed by private investigators in February, the Neue Zuercher Zeitung (NZZ) newspaper reported on Tuesday. The Swiss bank was rocked by a highly damaging...
Read More »Léman Express to cut Geneva traffic jams
[embedded content] Commuters got their first proper taste on Monday of what’s been hailed as the largest cross-border regional rail network in Europe, the Léman Express. The network, which opened officially on Sunday, is the result of decades of planning and almost eight years of construction work. It offers a fast cross-city rail link from Geneva’s central train station to Annemasse in France. The regional cross-border network is much bigger, extending across...
Read More »If The Best Case For Consumer Christmas Is That It Started Off In The Wrong Month…
Gone are the days when Black Friday dominated the retail calendar. While it used to be a somewhat fun way to kick off the holiday shopping season, it had morphed into something else entirely in later years. Scenes of angry shoppers smashing each other over the few big deals stores would truly offer, internet clips of crying children watching in horror as their parents transformed their local Walmart into Thunderdome. Two shoppers enter, one shopper leaves…with the...
Read More »The “Trade Deal”: A Pathetic Parody, Credibility Squandered
Anyone who thinks this bogus “deal” has resolved any of the issues or uncertainties deserves to be fired immediately. Here’s a late-night TV parody of a trade deal: The agreement won’t be signed by both parties, though each might sign their own version of it, and the terms of the deal will never ever be revealed to the public, which includes everyone doing any business in the nations doing the “deal.” How is this “deal” not a pathetic parody of a real deal? A real...
Read More »The US Economy Is Being Japanified — Thanks to the Fed
Japan has not recovered fully from the lost decade of the 1990s. The Asian financial crisis was exacerbated by the dot-com crash and then a few years later the global economic collapse. Tokyo has tried everything to combat anemic growth and deflation, and resolve the zombification of the Japanese economy through an immense buildup of government debt and a dramatic loosening of monetary policy, including subzero interest rates. This has become known as...
Read More »Gold Coins Worth Thousands Generously Donated To Salvation Army
Salvation Army volunteer James Bond found a gold coin valued at $1,500 inside his kettle in Noblesville. Source: Salvation Army via USA Today ◆ Gold coins worth thousands generously gifted to the charity again this year ◆ It just means so much … because it means that they went out of their way to do something extra special…” ◆ Salvation Army gold donors keep giving gold coins including Gold Krugerrands anonymously every year ◆ At least three gold coins worth some...
Read More »FX Daily, December 16: China Data Surprises to the Upside while Europe’s Manufacturing PMI Disappoints
Swiss Franc The Euro has risen by 0.05% to 1.095 EUR/CHF and USD/CHF, December 16(see more posts on EUR/CHF, USD/CHF, ) Source: markets.ft.com - Click to enlarge FX Rates Overview: Despite better than expected Chinese data, and last week’s investor-friendly developments, Asia Pacific equities were mixed. Australia led the advancing bourses with a 1.6% gain, its largest for the year despite the government revising down growth and wages. China, Taiwan, and Indian...
Read More »Novartis withdraws patent claim on leukaemia treatment
Novartis has aborted its latest patent filing at the European Patent Office. (Keystone / Georgios Kefalas) Swiss pharmaceutical giant Novartis has backed down in a patent dispute over the leukaemia therapy Kymriah following opposition from NGOs. The Swiss NGO Public Eye is claiming victory in the European Patent Officeexternal link battle, but Novartis says the patent in question was only one of several it has in place on the (CAR)-T cell therapy treatment it had...
Read More »FX Weekly Preview: Central Bank Meetings and Flash PMI Reports, but its Over except for the Shouting
After last week’s flurry of events, market activity is set to slow over the next three weeks. But what a flurry of events it was. A new NAFTA apparently has been agreed, and it is set to be approved by the US House of Representatives next week and the Senate early next year. The US and China struck an agreement that will get rid of the immediate tariff threat and unwind half of the punitive tariffs in exchange for a commitment to buy twice the amount of agriculture...
Read More »EM Preview for the Week Ahead
Risk assets such as EM got a big boost last week, as tail risks from a hard Brexit and the US-China trade war have clearly ebbed. Still, the initial lack of details on the Phase One deal as well as uncertainty regarding the next phases have left the markets a bit jittery and nervous. Hopefully, this week may bring some further clarity and the good news is that the December 15 tariffs have been canceled. AMERICAS Brazil COPOM minutes will be released Tuesday. It cut...
Read More »